Undescribed metastases within a pancreatic neuroendocrine tumour

63-year-old male hospitalised due to jaundice. CT scan showed a mass in the pancreatic body and tail with vascular damage and amputation of the common bile duct. Retroperitoneal lymph nodes of pathological appearance and a 20 mm subcutaneous nodule compatible with metastasis were also described. There were no liver metastases [1].

Ultrasound-guided core needle biopsy of the subcutaneous nodule and endoscopic ultrasonography-guided fine needle aspiration of the pancreatic mass showed a high-grade neuroendocrine tumour positive for synaptophysin, CD56, chromogranin and CK19 in both cases. The hormonal study was normal, so it was a nonfunctional neuroendocrine tumour.

The patient also reported odynophagia, identifying in the exploration a mass in the right palatine tonsil with a malignant appearance. The histological study revealed a high-grade neuroendocrine tumour with the same immunohistochemical characteristics as the other two samples (positive for synaptophysin, CD56, chromogranin and CK19). Therefore, it was a tonsillar metastasis of a non-functioning pancreatic neuroendocrine tumour.

We have not found any reports on a pancreatic neuroendocrine tumour with tonsillar metastasis (a previously undescribed location of metastasis), or primary neuroendocrine tumours of the tonsil making this an exceptional case.

 

Scroll to top

Conflicts of Interest

Authors do not have any conflict of interest to disclose.

• References

• 1 Fernandes et al. Gastroenterol Clin N Am. 51. 2022: 625-647

Publication History

Article published online:
27 March 2025